Press

London, February 25, 2025 – Bioniq, founded in 2019 and renowned for its personalized nutritional supplements based on blood biomarker data, is proud to announce that football star Diogo Dalot, right-back for Manchester United and the Portugal national team, has joined the company as an investor, contributing over €1 million. Dalot joins the global football icon Cristiano Ronaldo, who became a major investor in 2024, and brought Bioniq’s total valuation to $82 million. Dalot’s investment marks another milestone in Bioniq’s mission to make personalized health accessible to athletes and everyday individuals worldwide.

Bioniq's feature in Forbes highlights the company's innovative approach to personalized supplementation and its impact on the longevity market. The article emphasizes Bioniq's data-driven methodology, combining diagnostics like blood tests and accessible questionnaires with expert analysis to create bespoke supplement formulations. Founder Vadim Fedotov's vision, driven by his own frustrations with generic solutions, centers on empowering individuals with knowledge and personalized recommendations. Forbes underscores Bioniq's commitment to education, transparency, and data-backed results, which has attracted high-profile clients like Cristiano Ronaldo.

Already poised to reshape the global supplements market — projected to grow by 6.74% annually to reach $44.24 billion by 2029 — Bioniq is expanding its offerings with an ultimate solution tailored to the estimated 15% of the population with special health needs seeking personalized vitamins.

As 2024 comes to a close, we at Bioniq are filled with gratitude and pride. This year has been nothing short of extraordinary, marked by incredible milestones that have propelled us further on our mission to revolutionize personalized health and wellness. Here’s a look back at what made 2024 so remarkable.

Legendary football icon becomes a major shareholder in the leading company for personalized supplementation and health optimization.

Facilitated by our partnership with Truemed you may now use pre-tax dollars in your HSA and FSA accounts to step up your supplementation game with Bioniq!

Company will use funding to continue its global disruption of the existing one-size-fits-all supplement market

We are excited to partner with RMI - the world's leading stem cell longevity center.

Learn how Bioniq CEO Vadim Fedotov built our dream team

Bioniq is partnering with with meta[bolic], the pioneering hybrid healthcare company combining Digital Therapeutics (DTx) with human-centric clinical care

Bioniq is excited to announce Mike Thurston, an influential fitness expert and digital entrepreneur, as its inaugural "Bioniq Partner."

Bioniq is thrilled to announce the newest addition to our Advisory Board: Emma Thornton, a luminary in global marketing and brand strategy with a rich background in luxury, sports, health, and beauty sectors.

Bioniq is proud to announce that Matthijs Schellekens has joined its Advisory Board

Marni Allen joins as Global Chief Marketing Officer

bioniq is expanding together with the award-winning Longevity Clinic (longevity.kz)

Ahmad El-Dardiry joins as COO, Co-Founder and Board Director

AgFunderNews (AFN) interviewed Bioniq founder Vadim Fedotov about changing personalized health industry